Investors Land FIXX 6.3% Cheaper Than Its Secondary Stock Offering
April 09, 2021 at 10:21 AM EDT
Looking back to 2 days ago, Homology Medicines Inc (FIXX) priced a 6,329,113 share secondary stock offering at $7.90 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..
